Blackbird CEO, Ian McDonough, presents ‘enormous’ opportunities for flagship platform elevate.io. Watch the interview here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Oh dear, I bought more today. Clearly, I'm a master of betting against the odds! Looks like no tropical islands with fancy drinks for me this year. Guess I'll settle for a staycation with a kiddie pool and a paper umbrella in my drink!
A lot of big sells today. Someone knows something.
1000%
It went from $3 to $30
Someone clearly didn't think this could do a 1000X in a single day as was seen by Regencell Bioscience Holdings this week ;-)
@DSFLAT
Good and interesting posts
thanks
RGC has a $200M MCAP
The article by Daily Mail is what caught my attention this week (The Telegraph also covered the story)
" A 'miracle trial' claims that severe autism can be reversed and symptoms can be reduced if a child is treated regularly from a young age."
https://www.dailymail.co.uk/news/article-13654847/autism-reversed-symptoms-reduced-young-age-study.html?EdNo=051
Reversal of Autism Symptoms among Dizygotic Twins through a Personalized Lifestyle and Environmental Modification Approach: A Case Report and Review of the Literature
https://www.mdpi.com/2075-4426/14/6/641
Regencell Bioscience Holdings Ltd finished up 350% in todays trading. RGC don't appear to be related to the report but do provide a natural formula that shows promising results in case studies
https://www.regencellbioscience.com/
I'm more excited about the recent Cancer treatment possibilities for SFX-01 but whilst the Stalicla deal is still on the table new that severe Autism can be reversed could move the price or the Stalicla deal in the right direction.
Regencell Bioscience Holdings Ltd up 800% so far today in the US.
ASD treatment company, probably off the back of the news regarding the twins where one responded well to natural treatments...
Interesting to see how this affects TCF in the weeks/ months ahead
I hope your optimism and investment pays off.
I'm the only poster today and the only buyer 😄
The question I have is how long until news gets around about the results seen by Erasmus University Medical Center (see R&D presentation ) ?
Will Huw be jetting off to LA in October ?
https://www.msn.com/en-us/health/other/scientists-explore-potential-new-treatments-for-glioblastoma/ar-BB1pGKIl?ocid=BingNewsVerp
The potential of SFX-01 for treatment of rhabdomyosarcoma and Glioblastoma given recent updates is perhaps better than the Stalicla 'deal' and the use in treatment in Autism...
The US Food and Drug Administration (”FDA”) has granted an Orphan Drug Designation (“ODD”) for the use of SFX-01 to treat malignant glioma and Erasmus University Medical Center presentation in the R&D update was very impressive.
Initial modelling also shows promise in Colon Cancer.
The share price doesn't reflect any of the potential upside which could provide opportunity..
Certainly a share to keep a close eye on imo
The company using TCFs offering are refusing to pay out the milestone payment of £5.5 million (?) which is now due. So great caution required here in my opinion.
Some very encouraging news out about twins in the US and how one young girl responded to treatment..
Not related to TCF but suggests a cure or a least treatments are coming.
Might make Stalicla move things along ...
Yes ;-)
But I've got nearly 6M reasons to believe it will surpass 5p again so probably best to ignore me lol
This share caught my attention. Very low market cap given it has a deal in place whereby they will earn up to $160m in milestone payments. But concerned by how little money they have and the 5 year share price graph looks like a plane coming into land. What % chance of this recovering and reaching say 5p again?
Weird you cannot even buy 100,000 online atm after those sales yesterday. Looks like somebody took them.
Now Mr Kite looks to be averaging down I'm expecting him to add 10 to 20M shares..
We'll see via TR1's
Baffling somebody has sold 500k at 0.825p, probably the same buyer at 0.93p knowing this market
375k max though so not much on offer even after those sales of 1mil and 500k
The same chap who has invested in IMM?
Well done, very happy for you
You call me thick yet you cannot see the significance of 2 major share holders adding 2 days running. Jeez if that was CPX you would be having orgasm's over it :-))
18% spread and up 9% is it really?
davey,
i have now added this to my watchlist so i can reply here to you when you post your ****e elsewhere.
all the best
Davey,
Taking your own advice here and selling some then to protect your profits?